Combining PRP with prolotherapy can be synergistic, balancing biologic potency with serial stimulation of healing
It is typically administered by a healthcare professional in a hospital or clinic setting
Effect of combined applications of ALC+ASX on biomarkers of inflammation and OS, neurotransmitters, total antioxidant status (TAS), DNA, the DNA-damage repair enzymes including PARP-1 levels in substantia nigra and corpus striatum was examined
Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hnsel W et al (2005) Design of PAP-1, a selective small molecule K V 1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases